No data to show
XNAS
PIII
Market cap20mUSD
Jun 27, Last price
6.37USD
1D
3.41%
1Q
3,592.75%
IPO
-40.80%
Name
P3 Health Partners Inc
Chart & Performance
P/E
—
P/S
0.01
EPS
—
Div Yield, %
—
Shrs. gr., 5y
25.30%
Rev. gr., 5y
59.47%
Revenues
1.50b
+18.48%
Net income
-136m
L+135.14%
CFO
-110m
L+44.85%
Earnings
Aug 05, 2025
Profile
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | |||||||
Revenues | 1,500,455 18.48% | 1,266,375 20.66% | 1,049,500 -99.79% | ||||
Cost of revenue | 113,927 | 1,360,335 | 1,306,913 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 1,386,528 | (93,960) | (257,413) | ||||
NOPBT Margin | 92.41% | ||||||
Operating Taxes | 4,387 | 2,695 | 1,900 | ||||
Tax Rate | 0.32% | ||||||
NOPAT | 1,382,141 | (96,655) | (259,313) | ||||
Net income | (135,849) 135.14% | (57,773) -78.61% | (270,127) 2,579.57% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 86,595 | ||||||
BB yield | -20.85% | ||||||
| Debt | |||||||
Debt current | 65,000 | 1,600 | |||||
Long-term debt | 22,678 | 135,563 | 117,453 | ||||
Deferred revenue | (169) | ||||||
Other long-term liabilities | 126,137 | 5,992 | 6,311 | ||||
Net debt | 48,862 | 99,243 | 98,016 | ||||
| Cash flow | |||||||
Cash from operating activities | (110,128) | (76,028) | (126) | ||||
CAPEX | (1,827) | (2) | |||||
Cash from investing activities | 14,525 | (1,827) | (8) | ||||
Cash from financing activities | 98,771 | 100,332 | 11 | ||||
FCF | 1,514,313 | (117,819) | (113,712) | ||||
| Balance | |||||||
Cash | 38,816 | 36,320 | 17,537 | ||||
Long term investments | 3,500 | ||||||
Excess cash | |||||||
Stockholders' equity | (429,584) | (75,780) | 207,284 | ||||
Invested Capital | 781,589 | 637,375 | 636,338 | ||||
ROIC | 194.81% | ||||||
ROCE | 393.89% | ||||||
| EV | |||||||
Common stock shares outstanding | 146,998 | 294,590 | 41,579 | ||||
Price | 0.22 -84.05% | 1.41 -23.37% | 1.84 -73.86% | ||||
Market cap | 33,060 -92.04% | 415,372 442.93% | 76,505 -73.86% | ||||
EV | 155,515 | 806,147 | 691,326 | ||||
EBITDA | 1,472,586 | (7,285) | (257,326) | ||||
EV/EBITDA | 0.11 | ||||||
Interest | 22,173 | 15,985 | 11,400 | ||||
Interest/NOPBT | 1.60% | ||||||